{"filing":{"accession":"0001104659-26-099222","url":"/filing/0001104659-26-099222","form_type":"4","issuer_cik":"0001583648","issuer_name":"PALVELLA THERAPEUTICS, INC.","issuer_name_source":null,"issuer_ticker":"PVLA","issuer_url":"/issuer/0001583648","period_of_report":"2026-08-19","filed_date":"2026-08-20","acceptance_dt":"2026-08-20T16:05:17+00:00","acceptance_label":"2026-08-20 16:05 UTC","ingested_at":"2026-08-21T05:23:33.898496+00:00","ingested_label":"2026-08-21 05:23 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1583648/0001104659-26-099222-index.htm","day_url":"/filings/2026-08-20"},"owners":[{"owner_cik":"0001912570","owner_name":"Goin Kathleen","url":"/insider/0001912570","anchor":"owner-0001912570","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","is_director":false,"is_officer":true,"is_ten_percent":false,"is_other":false,"filing_anchor":"/filing/0001104659-26-099222#owner-0001912570"}],"line_owners":[{"owner_name":"Goin Kathleen","role":"Officer (Chief Operating Officer)"}],"transactions":[{"id":9299006,"accession":"0001104659-26-099222","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-099222","line_url":"/filing/0001104659-26-099222#line-1","is_derivative":false,"issuer_cik":"0001583648","issuer_name":"PALVELLA THERAPEUTICS, INC.","issuer_ticker":"PVLA","issuer_name_source":null,"issuer_url":"/issuer/0001583648","owner_cik":"0001912570","owner_name":"Goin Kathleen","owner_display_name":"Goin Kathleen","owner_url":"/insider/0001912570","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":151.39,"price_display":"151.39","price_state":"stated","total_value":227085.0,"total_display":"227,085.00","total_whole":"227,085","shares_owned_after":2802.0,"shares_owned_after_display":"2,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299007,"accession":"0001104659-26-099222","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-099222","line_url":"/filing/0001104659-26-099222#line-2","is_derivative":false,"issuer_cik":"0001583648","issuer_name":"PALVELLA THERAPEUTICS, INC.","issuer_ticker":"PVLA","issuer_name_source":null,"issuer_url":"/issuer/0001583648","owner_cik":"0001912570","owner_name":"Goin Kathleen","owner_display_name":"Goin Kathleen","owner_url":"/insider/0001912570","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1998.0,"shares_display":"1,998","price_per_share":151.7979,"price_display":"151.80","price_state":"stated","total_value":303292.2042,"total_display":"303,292.20","total_whole":"303,292","shares_owned_after":804.0,"shares_owned_after_display":"804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299008,"accession":"0001104659-26-099222","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-26-099222","line_url":"/filing/0001104659-26-099222#line-3","is_derivative":false,"issuer_cik":"0001583648","issuer_name":"PALVELLA THERAPEUTICS, INC.","issuer_ticker":"PVLA","issuer_name_source":null,"issuer_url":"/issuer/0001583648","owner_cik":"0001912570","owner_name":"Goin Kathleen","owner_display_name":"Goin Kathleen","owner_url":"/insider/0001912570","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":152.9975,"price_display":"153.00","price_state":"stated","total_value":61199.0,"total_display":"61,199.00","total_whole":"61,199","shares_owned_after":404.0,"shares_owned_after_display":"404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299009,"accession":"0001104659-26-099222","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-26-099222","line_url":"/filing/0001104659-26-099222#line-4","is_derivative":false,"issuer_cik":"0001583648","issuer_name":"PALVELLA THERAPEUTICS, INC.","issuer_ticker":"PVLA","issuer_name_source":null,"issuer_url":"/issuer/0001583648","owner_cik":"0001912570","owner_name":"Goin Kathleen","owner_display_name":"Goin Kathleen","owner_url":"/insider/0001912570","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102.0,"shares_display":"102","price_per_share":155.5898,"price_display":"155.59","price_state":"stated","total_value":15870.1596,"total_display":"15,870.16","total_whole":"15,870","shares_owned_after":302.0,"shares_owned_after_display":"302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299010,"accession":"0001104659-26-099222","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-26-099222","line_url":"/filing/0001104659-26-099222#line-5","is_derivative":false,"issuer_cik":"0001583648","issuer_name":"PALVELLA THERAPEUTICS, INC.","issuer_ticker":"PVLA","issuer_name_source":null,"issuer_url":"/issuer/0001583648","owner_cik":"0001912570","owner_name":"Goin Kathleen","owner_display_name":"Goin Kathleen","owner_url":"/insider/0001912570","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":302.0,"shares_display":"302","price_per_share":156.77,"price_display":"156.77","price_state":"stated","total_value":47344.54,"total_display":"47,344.54","total_whole":"47,345","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null}],"n_transactions":5,"line_constants":{"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true},"provenance":{"source_pass":"Layline","parse_status":"parsed","schema_version":null,"retrieved_at":"2026-08-21T05:23:33.898496+00:00","retrieved_label":"2026-08-21 05:23 UTC","primary_document":"https://www.sec.gov/Archives/edgar/data/1583648/0001104659-26-099222-index.htm","accepted_at":"2026-08-20T16:05:17+00:00","accepted_label":"2026-08-20 16:05 UTC"},"related":[],"related_rule":"Other filings held for the same issuer and the same period of report. This is a heuristic match, not an authoritative amendment link: the store holds no 4/A-to-original relation and the catalog does not invent one.","canonical_url":"https://ebomi.com/filing/0001104659-26-099222","retrieved_at":"2026-08-27T21:52:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}